PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “patent technologies”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 19 recordsLinked to original sources
PubMed1990

Patents and technology transfer.

Although the discovery and transfer of technology from universities to industry has been taking place for many years, the surge of activity in areas related to biotechnology, over the past fifteen years, has been remarkable. As the very essence of university research requires rapid publication of results, it is particularly important that timely patenting activity take place if an orderly and profitable transfer of technology is to occur.

Biotechnology↗
PubMed2025

Exploring precision medicine by utilizing individual genetic information for the management of Alzheimer's disease.

Alzheimer's Disease (AD) represents a formidable challenge in neurology, characterized by progressive neurodegeneration and cognitive decline. Traditional therapeutic approaches have failed to deliver significant outcomes, underscoring the need for innovative paradigms such as precision medicine. The review explores integrating genomic, biomarker-driven, and individualized therapeutic strategies to tackle AD. It examines the role of key genetic factors, including APOE and MTHFR polymorphisms, in influencing disease susceptibility and treatment responses. Advances in biomarker technologies, such as blood-based and imaging biomarkers, are highlighted for their potential in early diagnosis and patient stratification. Additionally, the review underscores the importance of tailoring interventions across different stages of AD, incorporating lifestyle modifications and emerging tools like artificial intelligence & recent patented technologies. Precision medicine offers a transformative pathway, aiming to deliver personalized, effective care that addresses the complex and multifactorial nature of AD. The paradigm shift promises improved clinical outcomes and enhanced patient quality of life.

Humans↗
PubMed1992

Genome research: fulfilling the public's expectations for knowledge and commercialization.

This article provides a historical perspective for the patenting of gene sequences and describes the fundamentals and evolution of patent law. It summarizes federal technology transfer law and policy and assesses the impacts of patenting on academic research. The patentability of gene sequences is then considered along with potential impacts that published sequence data may have on obtaining patent protection for downstream products. Industry's position on gene patenting is summarized and perspectives from the emerging public record on these issues are presented. The article discussing points at which the filing of patent applications and the licensing of patents may be appropriate. It concludes that technology transfer policies for genome research must be adopted carefully so that they remain viable in a time of rapid technological change.

Animals↗
PubMedDate not supplied

[Physicochemical examination of materials used for dentures for elaboration of individual composition of acrylic plastics].

It has been found that materials for dentures are obtained from poly (methyl methacrylate) as the basic component. Basing on the identification analysis of foreign acrylic plastics used for performing denture plates and literature and patent investigations a production technology of individual material calle Akpol S has been elaborated. Series of physicochemical comparative examinations of this composition and the foreign materials with regard to the requirements of ISO 1567 international standard have been carried out. It has been found that this material is comparable with the plastics of this type commonly used with regard to physicochemical features; a it also meets the requirements of the standard.

Denture Bases↗
PubMed1985

The patent system and cardiac pacing: is the system serving its users?

Patents have been utilized to protect technical innovations in pacemakers virtually since their inception and are becoming increasingly important to the industry. In the U.S. alone, about 100 patents are granted each year covering pacer-related technology and reflecting the main areas of technical development. The increase in the number of outstanding patents has been accompanied by a significant increase in patent litigation among pacer companies. The rate and cost of pacer-related patent litigation raises a question of whether the system is being used to its best advantage. A recommendation is made for an industry-sponsored board to aid in voluntary settlement of patent disputes.

Humans↗
PubMed1989

A better way.

Explore the source record for details and available documents.

Patents as Topic↗
PubMed1989

Life forms protectable as subjects of U.S. patents -- microbes to animals (perhaps).

Scientists, businessmen, universities and industries with fundamental or peripheral interests in technology as applied to life processes will be keenly interested in recent U.S. Patent Office decisions. These decisions indicate that new higher life forms, animal or plant, are proper subjects of patents if they are not naturally occurring (and are not human in the case of animals). In contrast to plants and other organisms, genetically modified animals have had no mode of protection as intellectual property except possibly as a trade secret or utility patent. The Ex parte Allen decision, reached by the Patent Office Board of Appeals and Interferences, directly addressed the issue of animal patentability in view of the broad reading of 35 U.S.C. section 101 by the U.S. Supreme Court in the Chakrabarty decision. The subject invention concerned polyploid oysters. Claims directed toward polyploid oysters produced by a particular process were rejected under 35 U.S.C. section 103 and section 101. The Board, reversing the 35 U.S.C. section 101 - based rejection in view of the Chakrabarty decision, indicated that the claimed polyploid oysters were non-naturally occurring manufactures or compositions of matter within the confines of patentable subject matter under 35 U.S.C. section 101. A similar decision affecting the patentable status of plants or segments thereof had previously been reached by the Patent and Trademark Office in the case of Ex parte Hibberd, 227 U.S.P.Q. 443 (Bd. Pat. App. 1985). The Hibberd utility patent application concerned "genetically engineered" maize which had high levels of the tryptophan.

Animals↗
PubMed1989

Inventing urine incontinence devices for women.

Nurses have long been aware of the devastating effects of urinary incontinence on women. Although women may find diapers, pads and protective clothing valuable protection, there are few options for a continuous wear, external urine incontinence device (EUID). Inventors have attempted to develop an EUID since ancient times; the first United States patent for an EUID was awarded in 1949. The purpose of this paper is to review technological considerations for development of an external urinary incontinence device for women. Patents and products illustrate the considerations.

Equipment Design↗
PubMed1990

Respiratory monitoring of the infant in anaesthesia and intensive care.

Respiratory monitoring of children during general anaesthesia and critical care is in its early stages. Acquisition of physical information remains of great importance because of the difficulties in obtaining specific and objective data from paediatric patients. Many of the obstacles presented by them, such as small and rapid respiration, lack of patient cooperation, use of an uncuffed tracheal tube and relatively higher airway humidity to keep the small airway patent, have been overcome recently by sophisticated technology based on well known principles and thoughtful use of computers. It is now possible to monitor and apply many pulmonary function tests at the bedside that were once confined to the laboratory.

Anesthesia, General↗
PubMed1978

The pharmaceutical industry: a further study in corporate power.

This article represents an updated version of previous research conducted on the United States pharmaceutical industry. The unstated purpose of this article is to present new findings which supplement the earlier research. This article describes three aspects of the United States pharmaceutical industry: its strategy and structure within the world market, its global expansion beyond the territorial boundaries of the United States, and its interlocking directorates with banking institutions. The thesis presented here is twofold: first, the United States pharmaceutical industry has become increasingly integrated into larger and more heterogeneous production units operating on the world market; and second, the United States pharmaceutical industry has become increasingly linked to large United States banking firms through interlocking directorates.

Drug Industry↗